Modelling the interplay between the CD4+/CD8+ T-cell ratio and the expression of MHC-I in tumours
Abstract
Describing the anti-tumour immune response as a series of cellular kinetic reactions from known immunological mechanisms, we create a mathematical model that shows the CD4+/CD8+ T-cell ratio, T-cell infiltration and the expression of MHC-I to be interacting factors in tumour elimination. Methods from dynamical systems theory and non-equilibrium statistical mechanics are used to model the T-cell dependent anti-tumour immune response. Our model predicts a critical level of MHC-I expression which determines whether or not the tumour escapes the immune response. This critical level of MHC-I depends on the helper/cytotoxic T-cell ratio. However, our model also suggests that the immune system is robust against small changes in this ratio. We also find that T-cell infiltration and the specificity of the intra-tumour TCR repertoire will affect the critical MHC-I expression. Our work suggests that the functional form of the time evolution of MHC-I expression may explain the qualitative behaviour of tumour growth seen in patients.Mathematics Subject Classification (2010) MSC 37C25 · MSC 82C99 · MSC 37N25 · MSC 92B99Competing Interest StatementThe authors have declared no competing interest.View Full Text
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The expression of class II major histocompatibility molecules on breast tumors delays T cell exhaustion, expands the T cell repertoire and slows tumor growth
T. McCaw, M. Li, … T. Randall·bioRxiv·Apr 3, 2018
- Mathematical Model Predicts Tumor Control Patterns Induced by Fast and Slow CTL Killing Mechanisms
Y. Wang, D. Bergman, … T. L. Jackson·bioRxiv·Jul 19, 2023
- Integrating Mathematical and Mouse Models Identifies T regulatory Cell Influx as a Key Determinant of Acquired Resistance to PD-1 Immunotherapy
Rachel S Sousa, Shannon N Geels, … Francesco Marangoni·Cancer ResearchPeer-reviewed·Aug 20, 2026
- Immune-cell depleted diffuse large B-cell lymphomas have reduced expression of MHC class I
Kanutte Huse, Yngvild Nuvin Blaker, … June H. Myklebust·bioRxiv·Sep 3, 2026
- MHC-I downregulation is associated with immune-evasion in breast cancers with heterogeneous activation of epithelial-mesenchymal plasticity
Kimaya M. Bakhle, Andreas Stephanou, … Anushka Dongre·bioRxiv·Oct 19, 2026
- Intratumoral cDC1-T Cell Clusters Serve as Sites of Local Costimulation to Enhance CTL-Mediated Tumor Rejection
Catherine B. Carbone, Markus K. Brown, … Christine Moussion·bioRxiv·May 19, 2025